NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines

Active specific immunotherapy is a promising field in cancer research. N-glycolyl (NGc) gangliosides, and particularly NGcGM3, have received attention as a privileged target for cancer therapy. Many clinical trials have been performed with the anti-NGc-containing gangliosides anti-idiotype monoclona...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Fernandez, Luis E., Gabri, Mariano R., Guthmann, Marcelo D., Gomez, Roberto E., Gold, Silvia, Fainboim, Leonardo, Gomez, Daniel E., Alonso, Daniel F.
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2010
Teme:
Review Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2965427/
https://ncbi.nlm.nih.gov/pubmed/21048926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/814397
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki